Praveg Limited Receives BSE Approval for Eulogia Inn Amalgamation Scheme
Praveg Limited has received BSE approval with 'no adverse observations' for its amalgamation scheme with Eulogia Inn Private Limited on January 21, 2026. The approval comes with 17 specific conditions covering disclosure requirements and compliance obligations. The scheme, initially approved by Praveg's board on April 23, 2025, still requires NCLT clearance and shareholder-creditor approvals from both companies.

*this image is generated using AI for illustrative purposes only.
Praveg Limited has achieved a significant milestone in its corporate restructuring plans, receiving regulatory clearance from BSE Limited for its proposed amalgamation with Eulogia Inn Private Limited. The observation letter with 'no adverse observations' was issued on January 21, 2026, marking a crucial step forward in the merger process.
Scheme Background and Timeline
The amalgamation scheme involves Eulogia Inn Private Limited as the transferor company and Praveg Limited as the transferee company. The Board of Directors of Praveg Limited initially approved this scheme of amalgamation on April 23, 2025, under Sections 230 to 232 of the Companies Act, 2013.
| Parameter | Details |
|---|---|
| Approval Date | January 21, 2026 |
| Initial Board Approval | April 23, 2025 |
| Transferor Company | Eulogia Inn Private Limited |
| Transferee Company | Praveg Limited |
| Regulatory Framework | Sections 230-232, Companies Act 2013 |
BSE Regulatory Conditions
BSE Limited has outlined 17 specific conditions that must be fulfilled as part of the amalgamation process. These conditions encompass comprehensive disclosure requirements, compliance obligations, and procedural mandates to ensure transparency and regulatory adherence.
Key Disclosure Requirements
The conditions mandate detailed disclosures including:
- Complete details of ongoing adjudication and recovery proceedings against the company, promoters, and directors
- Information about all unlisted companies involved in the scheme format as specified in Part E of Schedule VI of ICDR Regulations, 2018
- Details of assets, liabilities, net worth, and revenue of companies involved, both pre and post-scheme
- Impact assessment on revenue generating capacity of the transferee company
- Comprehensive rationale, synergies, and cost-benefit analysis of the scheme
Compliance and Procedural Mandates
Additional requirements include:
- Ensuring all financials used in the scheme and valuation report are not more than six months old
- Mandatory issuance of proposed equity shares in demat form only
- Incorporation of SEBI and stock exchange observations in the NCLT petition
- Disclosure of the no-objection letter on company website within 24 hours of receipt
- Compliance with all applicable provisions of Companies Act, 2013, and related rules
Pending Approvals and Next Steps
Despite receiving BSE's clearance, the amalgamation scheme remains subject to several additional statutory and regulatory approvals. The company must secure clearance from the National Company Law Tribunal (NCLT) and obtain approval from respective shareholders and creditors of both companies involved in the merger.
| Approval Status | Authority | Status |
|---|---|---|
| Stock Exchange | BSE Limited | ✓ Approved |
| Tribunal Approval | NCLT | Pending |
| Shareholder Approval | Both Companies | Pending |
| Creditor Approval | Both Companies | Pending |
The observation letter from BSE carries a validity period of six months from January 21, 2026, within which the scheme must be submitted to the NCLT as required under Regulation 37 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Regulatory Framework
The amalgamation is being conducted under Regulation 37 of SEBI LODR Regulations, 2015, in conjunction with SEBI Master Circular dated June 20, 2023. BSE has emphasized that its 'no adverse observations' status is limited to matters bearing on listing, de-listing, and continuous listing requirements within the provisions of the Listing Agreement.
The exchange has reserved its right to withdraw the 'no adverse observation' status if any submitted information is found to be incomplete, incorrect, misleading, or false, or for any contravention of exchange rules, bye-laws, and regulations.
Historical Stock Returns for Praveg
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.95% | -4.93% | -10.72% | -41.90% | -62.36% | +432.69% |












































